Global Gender Dysphoria Epidemiology Insight Report 2020: Treatment, Unmet Needs, Patient Population, Background and Overview

News provided by

Dec 22, 2020, 06:30 ET

DUBLIN, Dec. 22, 2020 /PRNewswire/ -- The "Gender Dysphoria - Epidemiology Insight - 2030" report has been added to ResearchAndMarkets.com's offering.

This 'Gender Dysphoria - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Gender Dysphoria epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Gender Dysphoria: Understanding

The publisher's gender dysphoria epidemiology report gives a thorough understanding of the condition by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for gender dysphoria in the US, Europe, and Japan. Moreover, the report covers detailed information on the gender dysphoria epidemiology scenario in seven major countries (US, EU5, and Japan).

Epidemiology Perspective:

This section encompassing gender dysphoria epidemiology provides insights about historical and current patient pool and forecasted trends for every seven major countries. The gender dysphoria epidemiology data are studied through all possible divisions to understand the Disease scenario in 7MM better. This segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports, and views of key opinion leaders.

Detailed Epidemiology Segmentation:

The gender dysphoria epidemiology covered in the report provides historical and forecasted epidemiology scenarios in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

The gender dysphoria report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns

The gender dysphoria report and model provide an overview of the global trends of gender dysphoria in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
The report provides insight into the historical and forecasted patient pool of gender dysphoria in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
The report assesses the disease risk and burden and highlights the unmet needs of gender dysphoria.
The report provides the segmentation of the gender dysphoria epidemiology

Report Highlights:

11-year Forecast of Gender Dysphoria Epidemiology
7MM Coverage
Prevalence of gender dysphoria
Gender-specific prevalence of gender dysphoria
Comorbidities associated with gender dysphoria

Key Topics Covered:

1 Key Insights

2 Executive Summary of Gender Dysphoria

3 SWOT Analysis for Gender Dysphoria

4 Gender Dysphoria Market Overview at a Glance
4.1 Market Share (%) Distribution of Gender Dysphoria in 2017
4.2 Market Share (%) Distribution of Gender Dysphoria in 2030

5 Disease Background and Overview
5.1 Introduction
5.2 Definitions
5.3 Etiology
5.4 Gender identity and Development of Gender Dysphoria
5.5 Pathophysiology
5.6 Diagnosis

6 Epidemiology and Patient Population
6.1 Key Findings
6.2 Total Prevalent Population of Gender Dysphoria
6.3 Assumptions and Rationale - 7MM

7 Country-wise epidemiology of Gender Dysphoria
7.1 The United States
7.1.1 Prevalence of Gender Dysphoria in the United States
7.1.2 Gender-specific Prevalence of Gender Dysphoria in the United States
7.1.3 Comorbidities Associated with Gender Dysphoria in the United States
7.2 Germany
7.3 France
7.4 Italy
7.5 Spain
7.6 United Kingdom
7.7 Japan

8 Treatment
8.1 Guidelines
World Professional Association for Transgender Health (WPATH) Guidelines
Endocrine Society Guidelines
8.2 Patient journey
8.3 Case Study
Title: Transgender Care in the Primary Care Setting
8.4 Access to healthcare services, insurance coverage and its impact on Trans people
8.5 Discrimination, social stigma, and other social issues

9 Unmet Needs

10 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/l5jdpb

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets